zyprexa intramuscular
Generic: olanzapine
Labeler: eli lilly and companyDrug Facts
Product Profile
Brand Name
zyprexa intramuscular
Generic Name
olanzapine
Labeler
eli lilly and company
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Routes
Active Ingredients
olanzapine 10 mg/2mL
Manufacturer
Identifiers & Regulatory
Product NDC
0002-7597
Product ID
0002-7597_9073f34c-307c-4a3a-8273-580ef5742229
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA021253
Marketing Start
2004-04-01
Marketing End
2026-06-30
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00027597
Hyphenated Format
0002-7597
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
zyprexa intramuscular (source: ndc)
Generic Name
olanzapine (source: ndc)
Application Number
NDA021253 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/2mL
Packaging
- 1 VIAL in 1 CARTON (0002-7597-01) / 2 mL in 1 VIAL
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "9073f34c-307c-4a3a-8273-580ef5742229", "openfda": {"nui": ["N0000175430"], "upc": ["0300024415300", "0300024116306", "0300024115309", "0300024420304", "0300024112308", "0300024117303"], "unii": ["N7U69T4SZR"], "rxcui": ["153046", "153047", "153048", "200034", "212405", "261337", "283639", "284514", "312076", "312077", "312078", "312079", "314154", "314155", "351107", "351108", "485968", "545353", "754503", "754504", "754505", "754506"], "spl_set_id": ["d5051fbc-846b-4946-82df-341fb1216341"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0002-7597-01) / 2 mL in 1 VIAL", "package_ndc": "0002-7597-01", "marketing_end_date": "20260630", "marketing_start_date": "20040401"}], "brand_name": "ZYPREXA Intramuscular", "product_id": "0002-7597_9073f34c-307c-4a3a-8273-580ef5742229", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "0002-7597", "generic_name": "Olanzapine", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZYPREXA", "brand_name_suffix": "Intramuscular", "active_ingredients": [{"name": "OLANZAPINE", "strength": "10 mg/2mL"}], "application_number": "NDA021253", "marketing_category": "NDA", "marketing_end_date": "20260630", "marketing_start_date": "20040401"}